| P50 | author | Fabrice Uhel | Q50741537 |
| P2093 | author name string | Angélique Goepp | |
| | Arnaud Gacouin | |
| | Guillaume Grillet | |
| | Jean-Marc Tadié | |
| | Julien Letheulle | |
| | Nicolas Barbarot | |
| | Pierre Bouju | |
| | Pierre Fillatre | |
| | Yves Le Tulzo | |
| P2860 | cites work | Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade | Q26741519 |
| | Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 |
| | Comparison of train-of-four and best clinical assessment during continuous paralysis | Q28254873 |
| | A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study | Q29615430 |
| | The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 |
| | Neuromuscular blockers in early acute respiratory distress syndrome | Q34023977 |
| | Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. | Q34113670 |
| | Paresis acquired in the intensive care unit: a prospective multicenter study | Q34163357 |
| | Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials | Q36902424 |
| | Physical complications in acute lung injury survivors: a two-year longitudinal prospective study | Q37646839 |
| | Pharmacodynamics of cisatracurium in the intensive care unit: an observational study | Q37717399 |
| | The use of neuromuscular blocking agents in the ICU: where are we now? | Q38099500 |
| | Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient | Q38984133 |
| | Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients | Q40357038 |
| | Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit | Q41134681 |
| | Neuromuscular Blocking Agents in ARDS | Q42906723 |
| | National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit | Q43452090 |
| | The interpretation of train-of-four monitoring in intensive care: what about the muscle site and the current intensity? | Q43702372 |
| | A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients | Q44226478 |
| | Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). | Q44473697 |
| | A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis | Q45108409 |
| | Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome | Q48034852 |
| | Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. | Q51576330 |
| | A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. | Q53967425 |
| | Controlled Sedation with Alphaxalone-Alphadolone | Q55061590 |
| | The Accuracy of Train-of four Monitoring at Varying Stimulating Currents | Q67747160 |
| | The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit | Q71126517 |
| | A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients | Q73321070 |
| | Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents | Q74313315 |
| | Neuromuscular monitoring by intensive care nurses: comparison of acceleromyography and tactile assessment | Q74637603 |
| | Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient | Q77788060 |
| | Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome | Q80166238 |
| | Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade | Q81367594 |
| | [Sedation and analgesia in intensive care (with the exception of new-born babies). French Society of Anesthesia and Resuscitation. French-speaking Resuscitation Society] | Q81521817 |
| | ICU-acquired weakness and recovery from critical illness | Q87386152 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | atracurium besylate | Q165660 |
| P304 | page(s) | 10 | |
| P577 | publication date | 2017-01-19 | |
| P1433 | published in | Annals of Intensive Care | Q18712109 |
| P1476 | title | Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study | |
| P478 | volume | 7 | |